Groups of mice were immunized intraperitoneally with HEp-2 lysate or respiratory syncytial virus (RSV)-infected HEp-2 cells with or without adjuvant(s). The animals were subsequently challenged intranasally (i.n.) with RSV and/or HEp-2 lysate and studied for RSV shedding in the lung, antigen-specific antibody response and pulmonary histopathology. A significant decrease in virus shedding was detected in each of four groups of animals immunized with a virus preparation and in two of four groups that received a HEp-2 lysate. Mice immunized with adjuvant(s) developed higher antibody-specific responses. All vaccinated animals developed pulmonary histopathology only on subsequent i.n. inoculation with RSV and/or HEp-2 lysate. Denatured extracts of purified RSV, HEp-2, BALB/c lung, cotton rat lung, Buffalo green monkey kidney and human buccal epithelium were tested for reactivity against the sera of immunized mice by an immunoblot method. Sera from all groups of immunized mice reacted with the extracts tested. The data suggest a possible role of reactivity to viral as well as non-viral components in the pathogenesis of RSV vaccine-induced pulmonary inflammation in the mouse model system.
CrowellR. L.,
FieldA. K.,
SchleifW. A.,
LongW. L.,
ColonnoR. J.,
MapolesJ. E.,
EminiE. A.1985; Monoclonal antibody that inhibits infection of HeLa and rhabdomyosarcoma cells by selected enteroviruses through receptor blockade. Journal of Virology 57:438–445
FernieB. F.,
CoteP. J.,
GerinJ. L.1982; Classification of hybridomas to respiratory syncytial virus glycoproteins. Proceedings of the Society for Experimental Biology and Medicine 171:266–271
FreihorstJ.,
PiedraP. A.,
OkamotoY.,
OgraP. L.1988; Effect of respiratory syncytial virus infection on the uptake of and immune response to other inhaled antigens. Proceedings of the Society of Experimental Biology and Medicine 188:191–197
FulginitiV. A.,
EllerJ. J.,
SieberO. F.,
JoynerJ. W.,
MinamitaniM.,
MeiklejohnG.1968; Respiratory virus immunization. I. Field trial of two inactivated respiratory virus vaccines : an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. American Journal of Epidemiology 89:435–448
HallC. B.,
HallW. J.,
GalaC. L.,
MagillF. B.,
LeddyJ. P.1984; Long-term prospective study in children after respiratory virus infection. Journal of Pediatrics 105:358–364
HendersonF. W.,
ClydeW. A.,
CollierA. M.,
DennyF. W.,
SeniorR. J.,
SheafferC. I.,
ConleyW. G.,
ChristianR. M.1979a; The etiologic and epidemiologic spectrum of bronchiolitis in pediatrie practice. Journal of Pediatrics 95:183–190
HendersonF. W.,
CollierA. M.,
ClydeW. A.,
DennyF. W.1979b; Respiratory syncytial virus infection, reinfection, and immunity: a prospective, longitudinal study in young children. New England Journal of Medicine 300:530–534
HuangY. T.,
WertzG. W.1982; The genome of respiratory syncytial virus is a negative stranded RNA that codes for at least seven mRNA species. Journal of Virology 43:150–157
KimH. W.,
CancholaJ. G.,
BrandtC. D.,
PylesG.,
ChanockR. M.,
JensenK.,
ParrottR. H.1968; Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. American Journal of Epidemiology 89:422–433
LehrerS. B.,
NakamuraR. M.,
TanE. M.1977; Histopathological changes in mice treated with extracts of the histamine-sensitizing factor of Bordetella pertussis. International Archives of Allergy and Applied Immunology 54:129–142
LeibovitzE.,
FreihorstJ.,
PiedraP. A.,
OgraP. L.1988; Modulation of systemic and mucosal immune responses to inhaled ragweed antigen in experimentally induced infection with respiratory syncytial virus implication in virally induced allergy. International Archives of Allergy and Applied Immunology 86:112–116
MontoA. S.,
BryanE. R.,
RhodesL. M.1975; The Tecumseh study of respiratory illness. VII. Further observations on the occurrence of respiratory syncytial virus and Mycoplasma pneumoniae infections. American Journal of Epidemiology 100:458–468
PrinceG. A.,
JensonA. B.,
HemmingV. G.,
MurphyB. R.,
WalshE. E.,
HorswoodR. L.,
ChanockR. M.1985; Enhancement of respiratory syncytial) virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactivated virus. Journal of Virology 57:721–728
ScottR.,
KaulA.,
ScottM.,
ChibaY.,
OgraP. L.1978; Development of in vitro correlation of cell mediated immunity to respiratory syncytial virus infection in man. Journal of Infectious Diseases 137:810–817
StottE. J.,
TaylorG.,
BallL. A.,
AndersonK.,
YoungK. K. Y.,
KingA. M. Q.,
WertzG. W.1987; Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus. Journal of Virology 61:3855–3861
TorreD. C.,
QuadrelliC.,
PuglieseA.,
MaggioloF.1986; Effect of betamethasone in lungs of mice treated with lymphocytosis-promoting factor of Bordetella pertussis. Journal of Infectious Diseases 154:238–244
TowbinH.,
StaehelinT.,
GordonJ.1979; Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of SciencesU.S.A 76:4350–4354
WalshE. E.,
HruskaJ.1983; Monoclonal antibodies to respiratory syncytial virus proteins. Identification of the fusion protein. Journal of Virology 47:171–177
WelliverR. C.,
KaulA.,
OgraP. L.1979; Cell-mediated immune response to respiratory syncytial virus infection: relationship to the development of reactive airway disease. Journal of Pediatrics 94:370–375
WelliverR. C.,
KaulT. N.,
PutnamT. I.,
SunM.,
RiddlesbergerK.,
OgraP. L.1980; The antibody response to primary and secondary infection with respiratory syncytial virus in kinetics of class-specific responses. Journal of Pediatrics 96:808–813
WongD. T.,
RosenbandM.,
HoveyK.,
OgraP. L.1985; Respiratory syncytial virus infection in immunosuppressed animals: implications in human infection. Journal of Medical Virology 17:359–370